Literature DB >> 32696097

Surgical Management of Primary Small Bowel NET Presenting Acutely with Obstruction or Perforation.

N S Rajaretnam1, G Y Meyer-Rochow2.   

Abstract

Up to 35% of small bowel neuroendocrine tumors (SBNETs) may present with an acute intra-abdominal complication including obstruction, perforation, bleeding or ischemia and may require emergency surgical treatment in centers not normally accustomed to managing patients with neuroendocrine tumors. These patients may have a known diagnosis of SBNET, be suspected as suffering from SBNET or have SBNET diagnosed as an incidental finding on presenting radiology or postoperative pathology. Perioperative priorities include obtaining both clinical and radiological staging with cross-sectional imaging and clinical examination, screening for the presence of carcinoid syndrome and right-sided cardiac disease and assessment of prognosis. Intraoperatively careful attention should be paid to noting the presence and location of multifocal primary and metastatic disease. Ideally, surgical resection with mesenteric lymph node dissection is the treatment of choice for obstructing and perforating lesions. Extended lymphadenectomy along the SMA, SMV and behind the pancreas should be primarily considered an elective procedure. In unwell patients with advanced disease surgical bypass (jejuno or ileocolic) or proximal defunctioning should be undertaken but, given the excellent long-term survivals in patients with stage IV disease, could be considered bridging procedures to elective resection following formal staging and multidisciplinary review.

Entities:  

Mesh:

Year:  2020        PMID: 32696097     DOI: 10.1007/s00268-020-05689-7

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  4 in total

Review 1.  Frozen section of the gastrointestinal tract, appendix, and peritoneum.

Authors:  Mamoun Younes
Journal:  Arch Pathol Lab Med       Date:  2005-12       Impact factor: 5.534

2.  Resection of at-risk mesenteric lymph nodes is associated with improved survival in patients with small bowel neuroendocrine tumors.

Authors:  Christine S Landry; Heather Y Lin; Alexandria Phan; Chusilp Charnsangavej; Eddie K Abdalla; Thomas Aloia; J Nicolas Vauthey; Matthew H G Katz; James C Yao; Jason B Fleming
Journal:  World J Surg       Date:  2013-07       Impact factor: 3.352

3.  Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center.

Authors:  Olov Norlén; Peter Stålberg; Kjell Öberg; John Eriksson; Jakob Hedberg; Ola Hessman; Eva Tiensuu Janson; Per Hellman; Göran Åkerström
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

4.  Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases.

Authors:  Per Hellman; Tobias Lundström; Ulf Ohrvall; Barbro Eriksson; Britt Skogseid; Kjell Oberg; Eva Tiensuu Janson; Göran Akerström
Journal:  World J Surg       Date:  2002-05-21       Impact factor: 3.352

  4 in total
  2 in total

Review 1.  How to Select Patients Affected by Neuroendocrine Neoplasms for Surgery.

Authors:  Francesca Fermi; Valentina Andreasi; Francesca Muffatti; Stefano Crippa; Domenico Tamburrino; Stefano Partelli; Massimo Falconi
Journal:  Curr Oncol Rep       Date:  2022-01-25       Impact factor: 5.075

2.  Analysis of Placement Priorities and Nursing Countermeasures of Transnasally Inserted Intestinal Obstruction Catheters in Patients with Acute Small Bowel Obstruction.

Authors:  Xiaoli Qian; Wei Yan
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-29       Impact factor: 2.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.